Physician profile
William J Dibble
NPI 1356301774
$7,105.38
in general payments reported to CMS, 2019-2025
34 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,569 · 2020: $335 · 2021: $283 · 2022: $351 · 2023: $1,654 · 2024: $1,584 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,566.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,147.12 | 2019-2025 | |
| Abbvie INC. | $1,056.01 | 2019-2025 | Vraylar, Ubrelvy, Synthroid |
| Glaxosmithkline, LLC. | $733.62 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $728.60 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $336.89 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $319.41 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbott Laboratories | $267.49 | 2023-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals Lp | $264.90 | 2019-2025 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.42 | 2019-2025 | Tradjenta, Synjardy, Jardiance |
| Novo Nordisk INC | $260.79 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $191.34 | 2019-2023 | Gardasil 9 |
| Exact Sciences Corporation | $185.58 | 2023-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $133.25 | 2023-2024 | Accrufer |
| Amarin Pharma, INC. | $118.61 | 2019-2021 | |
| Intuitive Surgical, INC. | $109.67 | 2025 |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dibble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.